CD14 and chronic obstructive pulmonary disease: The proportion of CD14+CD16+ monocytes from COPD patients expressing CCR5 was significantly greater than S (medians 14.3% versus 4.9%; p < 0.05) but did not reach statistical significance compared to HNS (median 2.7%, p = 0.09).